Patent AnalyticsExaminers
Menu

Topic

Cell lung cancer Steady

268 applications whose title mentions it. Its share of new filings over the last two years is 11% above the four years before.

Allowance rate
55%
−20 pts vs the USPTO 211 decided
Months to first action
18.5 mo
−0.1 vs the USPTO
Applications
268.0
in the record
Allowed
116.0
95 abandoned

Filings by year

How often the topic was filed

The most recent years are still filling in.

Applications

Recent applications on this topic

ApplicationTitleFiledStatusRejectionsRCEsTo 1st action
19621515USE OF PLK1 INHIBITOR AND PACLITAXEL IN TREATING SMALL CELL LUNG CANCER2026-09-04Pending00n/a
19611335TREATMENT OF LIMITED-STAGE SMALL-CELL LUNG CANCER WITH PD-L1 INHIBITORS2026-07-31Pending00n/a
19609523USE OF QUINAZOLINE COMPOUND AND THIRD-GENERATION EGFR INHIBITOR IN A COMBINATION ME…2026-07-26Pending00n/a
15603007Method and apparatus for adaptive signal processing2012-01-10Allowed1012.0 mo
15434143Composition and method for controlled release2015-02-11Abandoned4123.0 mo
15461729Distributed ledger transaction verification2018-03-12Allowed3020.0 mo
15854811Thermal management of battery assemblies2021-04-13Pending2117.0 mo
15900842Machine learning model for anomaly detection2012-05-14Allowed1014.0 mo
15813457Wireless power transfer coil arrangement2015-06-15Abandoned4125.0 mo
15294739Catalyst for selective hydrogenation2018-07-16Allowed3022.0 mo
Unlock every application on this topic, with its timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in